SBIO holdings — ALPS Medical Breakthroughs ETF
ALPS Medical Breakthroughs ETF (SBIO) held 89 positions with net assets of $162M as of May 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 34.8% of the fund, led by ALKS, KYMR, CELC.
SBIO top holdings
- ALKS Alkermes Plc — 4.48% ($7.24M)
- KYMR Kymera Therapeutics Inc — 4.23% ($6.85M)
- CELC Celcuity Inc — 3.92% ($6.34M)
- MIRM Mirum Pharmaceuticals Inc — 3.90% ($6.31M)
- SYRE Spyre Therapeutics Inc — 3.68% ($5.95M)
- CGON Cg Oncology Inc — 3.35% ($5.42M)
- APGE Apogee Therapeutics Inc — 2.93% ($4.74M)
- XENE Xenon Pharmaceuticals Inc — 2.90% ($4.69M)
- TVTX Travere Therapeutics Inc — 2.77% ($4.48M)
- DNTH Dianthus Therapeutics Inc — 2.64% ($4.26M)
- NAMS Newamsterdam Pharma Co Nv — 2.47% ($3.99M)
- VKTX Viking Therapeutics Inc — 2.41% ($3.90M)
- Crinetics Pharmaceuticals Inc — 2.37% ($3.84M)
- ACAD Acadia Pharmaceuticals Inc — 2.35% ($3.81M)
- EWTX Edgewise Therapeutics Inc — 2.33% ($3.78M)
- DNLI Denali Therapeutics Inc — 2.13% ($3.44M)
- ORKA Oruka Therapeutics Inc — 1.81% ($2.92M)
- GPCR Structure Therapeutics Inc — 1.78% ($2.87M)
- IRON Disc Medicine Inc — 1.69% ($2.74M)
- IDYA Ideaya Biosciences Inc — 1.65% ($2.67M)
- VERA Vera Therapeutics Inc — 1.61% ($2.61M)
- TARS Tarsus Pharmaceuticals Inc — 1.61% ($2.61M)
- RLAY Relay Therapeutics Inc — 1.60% ($2.59M)
- MLYS Mineralys Therapeutics Inc — 1.59% ($2.57M)
- CLDX Celldex Therapeutics Inc — 1.33% ($2.16M)
What are SBIO's top 10 holdings?
ALKS (4.5%), KYMR (4.2%), CELC (3.9%), MIRM (3.9%), SYRE (3.7%), CGON (3.4%), APGE (2.9%), XENE (2.9%), TVTX (2.8%), DNTH (2.6%).
How many stocks are in SBIO?
ALPS Medical Breakthroughs ETF reported 89 holdings as of May 31, 2026.